We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
12476
PUT
Alaunos Therapeutics
TCRT
$4.71M
$113K ﹤0.01%
692
-300
-30% -$65.9K
UAVS icon
12477
PUT
AgEagle Aerial Systems
UAVS
$63.9M
$113K ﹤0.01%
72
+7
+11% +$17K
CD
12478
PUT
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$113K ﹤0.01%
17,100
-5,700
-25% -$48.8K
EQHA.WS
12479
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$113K ﹤0.01%
217,440
-13,303
-6% -$7.58K
ACII.WS
12480
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$113K ﹤0.01%
138,615
-73,427
-35% -$66.3K
CRU.WS
12481
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$113K ﹤0.01%
159,153
+403
+0.3% +$327
ABEO icon
12482
Abeona Therapeutics
ABEO
$343M
$112K ﹤0.01%
+13,308
New +$244K
CIK
12483
Credit Suisse Asset Management Income Fund
CIK
$134M
$112K ﹤0.01%
32,619
+8,215
+34% +$28.3K
IBIO icon
12484
CALL
iBio
IBIO
$71M
$112K ﹤0.01%
410
+165
+67% +$62.9K
NCTY
12485
The9 Ltd
NCTY
$70M
$112K ﹤0.01%
1,660
-4,160
-71% -$422K
NEWP
12486
New Pacific Metals
NEWP
$1.27B
$112K ﹤0.01%
38,261
-41,310
-52% -$135K
RYTM icon
12487
CALL
Rhythm Pharmaceuticals
RYTM
$7.95B
$112K ﹤0.01%
11,200
-1,500
-12% -$16.9K
SIFY
12488
PUT
Sify Technologies
SIFY
$1.13B
$112K ﹤0.01%
5,783
-167
-3% -$3.4K
BMAQ
12489
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
$112K ﹤0.01%
+11,474
New +$112K
ALR
12490
DELISTED
AlerisLife Inc
ALR
$112K ﹤0.01%
+38,098
New +$139K
BCACU
12491
DELISTED
Brookline Capital Acquisition Corp. Units
BCACU
$112K ﹤0.01%
10,993
-1,979
-15% -$20.3K
MACUW
12492
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
$112K ﹤0.01%
400,000
-38
-0% -$12
AUTL
12493
PUT
Autolus Therapeutics
AUTL
$572M
$111K ﹤0.01%
21,400
-23,300
-52% -$140K
IRD
12494
PUT
Opus Genetics
IRD
$300M
$111K ﹤0.01%
29,800
-3,900
-12% -$15.6K
NPKI
12495
PUT
NPK International
NPKI
$1.21B
$111K ﹤0.01%
37,700
-14,100
-27% -$45.3K
VHAQ.WS
12496
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$111K ﹤0.01%
515,231
-346
-0.1% -$94
FVT.WS
12497
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$111K ﹤0.01%
140,000
-19,329
-12% -$18.5K
BTAQU
12498
DELISTED
Burgundy Technology Acquisition Corporation Unit
BTAQU
$111K ﹤0.01%
10,821
-11
-0.1% -$113
PGRE
12499
CALL
DELISTED
Paramount Group
PGRE
$110K ﹤0.01%
13,200
-3,500
-21% -$31K
SRTY icon
12500
ProShares UltraPro Short Russell2000
SRTY
$65.3M
$110K ﹤0.01%
+657
New +$112K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.